Rifoldin Dragees
Recall
|
Medicines
|
10/02/2015
The marketing authorization holder informed its supplied customers in a letter dated February 9, 2015, that the specified batches were being recalled because deviations from the specified dissolution value had been detected in the samples returned.
| Name of the medicinal product | Rifoldin 600 mg Dragees |
|---|---|
| Marketing authorisation number(s) | 15.693 |
| Marketing authorisation holder | sanofi-aventisGmbH, 1220 Wien |
| Batch number(s) | 3J298A, 3D253A, 2L195A, 2E172A |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-1335 |
Further inquiry note
Page last modified:
12/07/2022